| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
-Defensins 2 and 3 by Elastolytic Cathepsins1
* Pulmonary Research Division, Department of Medicine, Royal College of Surgeons in Ireland, Education and Research Center, Beaumont Hospital; and
Department of Microbiology, Moyne Institute, Trinity College Dublin, Ireland;
Laboratory of Biochemistry, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892; and
Department of Pediatrics, University of Iowa College of Medicine, Iowa City, IA 52242
-Defensins are antimicrobial peptides that contribute to the innate immune responses of eukaryotes. At least three defensins, human -defensins 1, 2, and 3 (HBD-1, -2, and -3), are produced by epithelial cells lining the respiratory tract and are active toward Gram-positive (HBD-3) and Gram-negative (HBD-1, -2, and -3) bacteria. It has been postulated that the antimicrobial activity of defensins is compromised by changes in airway surface liquid composition in lungs of patients with cystic fibrosis (CF), therefore contributing to the bacterial colonization of the lung by Pseudomonas and other bacteria in CF. In this report we demonstrate that HBD-2 and HBD-3 are susceptible to degradation and inactivation by the cysteine proteases cathepsins B, L, and S. In addition, we show that all three cathepsins are present and active in CF bronchoalveolar lavage. Incubation of HBD-2 and -3 with CF bronchoalveolar lavage leads to their degradation, which can be completely (HBD-2) or partially (HBD-3) inhibited by a cathepsin inhibitor. These results suggest that -defensins are susceptible to degradation and inactivation by host proteases, which may be important in the regulation of -defensin activity. In chronic lung diseases associated with infection, overexpression of cathepsins may lead to increased degradation of HBD-2 and -3, thereby favoring bacterial infection and colonization.
This article has been cited by other articles:
|
|
 |
|
  J. R. Mastroianni and A. J. Ouellette {alpha}-Defensins in Enteric Innate Immunity: FUNCTIONAL PANETH CELL {alpha}-DEFENSINS IN MOUSE COLONIC LUMEN J. Biol. Chem., October 9, 2009; 284(41): 27848 - 27856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Bergsson, E. P. Reeves, P. McNally, S. H. Chotirmall, C. M. Greene, P. Greally, P. Murphy, S. J. O'Neill, and N. G. McElvaney LL-37 Complexation with Glycosaminoglycans in Cystic Fibrosis Lungs Inhibits Antimicrobial Activity, Which Can Be Restored by Hypertonic Saline J. Immunol., July 1, 2009; 183(1): 543 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Wilson, A. P. Schmidt, E. Pirila, E. V. Valore, N. Ferri, T. Sorsa, T. Ganz, and W. C. Parks Differential Processing of {alpha}- and {beta}-Defensin Precursors by Matrix Metalloproteinase-7 (MMP-7) J. Biol. Chem., March 27, 2009; 284(13): 8301 - 8311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Guyot, M. W. Butler, P. McNally, S. Weldon, C. M. Greene, R. L. Levine, S. J. O'Neill, C. C. Taggart, and N. G. McElvaney Elafin, an Elastase-specific Inhibitor, Is Cleaved by Its Cognate Enzyme Neutrophil Elastase in Sputum from Individuals with Cystic Fibrosis J. Biol. Chem., November 21, 2008; 283(47): 32377 - 32385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Geraghty, M P Rogan, C M Greene, M L Brantly, S J O'Neill, C C Taggart, and N G McElvaney Alpha-1-antitrypsin aerosolised augmentation abrogates neutrophil elastase-induced expression of cathepsin B and matrix metalloprotease 2 in vivo and in vitro Thorax, July 1, 2008; 63(7): 621 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cooley, B. McDonald, F. J. Accurso, E. C. Crouch, and E. Remold-O'Donnell Patterns of neutrophil serine protease-dependent cleavage of surfactant protein D in inflammatory lung disease J. Leukoc. Biol., April 1, 2008; 83(4): 946 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Harder, R. Glaser, and J.-M. Schroder Review: Human antimicrobial proteins effectors of innate immunity Innate Immunity, December 1, 2007; 13(6): 317 - 338. [Abstract] [PDF]
|
|
|
|
|
|
P. Geraghty, C. M. Greene, M. O'Mahony, S. J. O'Neill, C. C. Taggart, and N. G. McElvaney Secretory Leucocyte Protease Inhibitor Inhibits Interferon-{gamma}-induced Cathepsin S Expression J. Biol. Chem., November 16, 2007; 282(46): 33389 - 33395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Huang, R. L. Redfern, S. Narayanan, R. Y. Reins, and A. M. McDermott In Vitro Activity of Human {beta}-Defensin 2 against Pseudomonas aeruginosa in the Presence of Tear Fluid Antimicrob. Agents Chemother., November 1, 2007; 51(11): 3853 - 3860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Geraghty, M. P. Rogan, C. M. Greene, R. M. M. Boxio, T. Poiriert, M. O'Mahony, A. Belaaouaj, S. J. O'Neill, C. C. Taggart, and N. G. McElvaney Neutrophil Elastase Up-Regulates Cathepsin B and Matrix Metalloprotease-2 Expression J. Immunol., May 1, 2007; 178(9): 5871 - 5878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Hiemstra Antimicrobial peptides in the real world: implications for cystic fibrosis Eur. Respir. J., April 1, 2007; 29(4): 617 - 618. [Full Text] [PDF]
|
|
|
|
|
|
H. Ishimoto, H. Mukae, Y. Date, T. Shimbara, M. S. Mondal, J. Ashitani, T. Hiratsuka, S. Kubo, S. Kohno, and M. Nakazato Identification of hBD-3 in respiratory tract and serum: the increase in pneumonia Eur. Respir. J., February 1, 2006; 27(2): 253 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Altiok, R. Yasumatsu, G. Bingol-Karakoc, R. J. Riese, M. T. Stahlman, W. Dwyer, R. A. Pierce, D. Bromme, E. Weber, and S. Cataltepe Imbalance between Cysteine Proteases and Inhibitors in a Baboon Model of Bronchopulmonary Dysplasia Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 318 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Starner and P. B. McCray Jr. Pathogenesis of Early Lung Disease in Cystic Fibrosis: A Window of Opportunity To Eradicate Bacteria Ann Intern Med, December 6, 2005; 143(11): 816 - 822. [Full Text] [PDF]
|
|
|
|
|
|
R. T. Sadikot, T. S. Blackwell, J. W. Christman, and A. S. Prince Pathogen-Host Interactions in Pseudomonas aeruginosa Pneumonia Am. J. Respir. Crit. Care Med., June 1, 2005; 171(11): 1209 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Taggart, C. M. Greene, T. P. Carroll, S. J. O'Neill, and N. G. McElvaney Elastolytic Proteases: Inflammation Resolution and Dysregulation in Chronic Infective Lung Disease Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1070 - 1076. [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Liboni, N. Li, P. O. Scumpia, and J. Neu Glutamine Modulates LPS-Induced IL-8 Production through I{kappa}B/NF-{kappa}B in Human Fetal and Adult Intestinal Epithelium J. Nutr., February 1, 2005; 135(2): 245 - 251. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
